002688 金河生物
已收盘 05-21 15:00:00
资讯
新帖
简况
股市必读：金河生物（002688）5月20日董秘有最新回复
证券之星 · 02:45
股市必读：金河生物（002688）5月20日董秘有最新回复
金河生物：吉林佑本生产基地主要用于特种疫苗生产
证券之星 · 05-20 11:35
金河生物：吉林佑本生产基地主要用于特种疫苗生产
金河生物（002688）披露子公司获得猪乙型脑炎灭活疫苗兽药产品批准文号，5月8日股价上涨0.5%
证券之星 · 05-08
金河生物（002688）披露子公司获得猪乙型脑炎灭活疫苗兽药产品批准文号，5月8日股价上涨0.5%
股市必读：金河生物（002688）4月30日披露最新机构调研信息
证券之星 · 05-06
股市必读：金河生物（002688）4月30日披露最新机构调研信息
每周股票复盘：金河生物（002688）股东户数降7.49%
证券之星 · 05-03
每周股票复盘：金河生物（002688）股东户数降7.49%
金河生物（002688）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 04-30
金河生物（002688）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：金河生物年报 - 第四季度单季净利润同比下降722.31%
证券之星 · 04-30
股市必读：金河生物年报 - 第四季度单季净利润同比下降722.31%
图解金河生物年报：第四季度单季净利润同比下降722.31%
证券之星 · 04-29
图解金河生物年报：第四季度单季净利润同比下降722.31%
金河生物（002688）股东内蒙古金河控股有限公司质押2870万股，占总股本3.73%
证券之星 · 04-24
金河生物（002688）股东内蒙古金河控股有限公司质押2870万股，占总股本3.73%
金河生物（002688）股东内蒙古金河控股有限公司质押1505万股，占总股本1.96%
证券之星 · 04-20
金河生物（002688）股东内蒙古金河控股有限公司质押1505万股，占总股本1.96%
金河生物：猪口蹄疫合成肽疫苗正在申请创新性评价注册工作
证券之星 · 04-08
金河生物：猪口蹄疫合成肽疫苗正在申请创新性评价注册工作
金河生物：虾青素产品为红法夫酵母代谢产物
证券之星 · 04-08
金河生物：虾青素产品为红法夫酵母代谢产物
股市必读：金河生物（002688）4月3日收盘跌5.7%，主力净流出3471.09万元
证券之星 · 04-07
股市必读：金河生物（002688）4月3日收盘跌5.7%，主力净流出3471.09万元
金河生物（002688）披露2023年限制性股票激励计划部分已授予限制性股票回购注销完成公告，3月30日股价上涨0.68%
证券之星 · 03-30
金河生物（002688）披露2023年限制性股票激励计划部分已授予限制性股票回购注销完成公告，3月30日股价上涨0.68%
股市必读：金河生物（002688）3月20日收盘跌5.83%，主力净流出4340.98万元
证券之星 · 03-23
股市必读：金河生物（002688）3月20日收盘跌5.83%，主力净流出4340.98万元
金河生物（002688）披露关于注销部分募集资金专户的公告，3月10日股价上涨0.49%
证券之星 · 03-10
金河生物（002688）披露关于注销部分募集资金专户的公告，3月10日股价上涨0.49%
金河生物（002688）披露变更募集资金用途后重新开立募集资金专户并签订监管协议公告，3月4日股价下跌0.67%
证券之星 · 03-04
金河生物（002688）披露变更募集资金用途后重新开立募集资金专户并签订监管协议公告，3月4日股价下跌0.67%
金河生物：美伊冲突对公司海外市场影响甚微
证券之星 · 03-03
金河生物：美伊冲突对公司海外市场影响甚微
金河生物（002688）披露2026年第二次临时股东会决议，2月27日股价上涨0.16%
证券之星 · 02-27
金河生物（002688）披露2026年第二次临时股东会决议，2月27日股价上涨0.16%
金河生物：2025年公司全面开辟国内反刍动物及海外市场
证券之星 · 02-02
金河生物：2025年公司全面开辟国内反刍动物及海外市场
暂无数据
公司概况
公司名称：
金河生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2012-07-13
主营业务：
金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化学药品、兽用生物制品、药物饲料添加剂、环保业务、淀粉及联产品。
发行价格：
18.00
{"stockData":{"symbol":"002688","market":"SZ","secType":"STK","nameCN":"金河生物","latestPrice":5.67,"timestamp":1779346980000,"preClose":5.82,"halted":0,"volume":7049833,"delay":0,"changeRate":-0.0258,"floatShares":747000000,"shares":770000000,"eps":0.0504,"marketStatus":"已收盘","change":-0.15,"latestTime":"05-21 15:00:00","open":5.84,"high":5.88,"low":5.67,"amount":40743400,"amplitude":0.0361,"askPrice":5.68,"askSize":991,"bidPrice":5.67,"bidSize":399,"shortable":0,"etf":0,"ttmEps":0.0504,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.82,"symbolType":"stock","openAndCloseTimeList":[[1779327000000,1779334200000],[1779339600000,1779346800000]],"highLimit":6.4,"lowLimit":5.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":769504398,"isCdr":false,"pbRate":1.96,"roa":"--","peRate":112.5,"roe":"2.76%","epsLYR":0.0353,"committee":-0.342007,"marketValue":4363000000,"turnoverRate":0.0094,"status":1,"floatMarketCap":4238000000},"requestUrl":"/m/hq/s/002688/tweets","defaultTab":"tweets","newsList":[{"id":"2637276568","title":"股市必读：金河生物（002688）5月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637276568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637276568?lang=zh_cn&edition=full","pubTime":"2026-05-21 02:45","pubTimestamp":1779302712,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，金河生物报收于5.82元，下跌1.85%，换手率0.82%，成交量6.16万手，成交额3600.23万元。董秘最新回复投资者： 你好，请问作为公司四个生产基地中最晚建成的吉林佑本基地，预计未来五年或者更长的时间是否有较为详细规划以及产品发展方向，谢谢董秘： 您好，吉林佑本生产基地，主要用于特种疫苗生产。感谢您对公司的关注！交易信息汇总资金流向5月20日主力资金净流出641.32万元；游资资金净流入207.28万元；散户资金净流入434.04万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100002683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636892470","title":"金河生物：吉林佑本生产基地主要用于特种疫苗生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2636892470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636892470?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:35","pubTimestamp":1779248124,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问作为公司四个生产基地中最晚建成的吉林佑本基地，预计未来五年或者更长的时间是否有较为详细规划以及产品发展方向，谢谢金河生物回复：您好，吉林佑本生产基地，主要用于特种疫苗生产。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000018991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159646","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633945700","title":"金河生物（002688）披露子公司获得猪乙型脑炎灭活疫苗兽药产品批准文号，5月8日股价上涨0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633945700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633945700?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:36","pubTimestamp":1778250973,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，金河生物报收于6.0元，较前一交易日上涨0.5%，最新总市值为46.17亿元。金河生物科技股份有限公司近日发布公告称，其子公司杭州佑本动物疫苗有限公司获得农业农村部核发的《兽药产品批准文号批件》，通用名称为猪乙型脑炎灭活疫苗，有效期至2031年5月5日，监测期至2029年5月5日。该产品已取得批准文号，无需再履行其他审批程序，公司可组织生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800043850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633921338","title":"股市必读：金河生物（002688）4月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2633921338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633921338?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:23","pubTimestamp":1778012589,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，金河生物报收于6.02元，上涨0.0%，换手率1.41%，成交量10.51万手，成交额6325.32万元。来自机构调研要点：2025年金霉素国内外市场销量增长且价格上调，推动毛利率提升。机构调研要点2025年及2026年一季度，金霉素国内市场需求扩大，销量增长；美国市场销量稳中有升，并积极开拓其他外销市场，六期项目投产保障供应。2025年公司对金霉素产品进行价格上调，提升利润空间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632672709","title":"每周股票复盘：金河生物（002688）股东户数降7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632672709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632672709?lang=zh_cn&edition=full","pubTime":"2026-05-03 05:04","pubTimestamp":1777755853,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，金河生物报收于6.02元，较上周的5.81元上涨3.61%。本周，金河生物4月29日盘中最高价报6.05元。股本股东变化截至2026年3月31日，金河生物股东户数为4.8万户，较2025年12月31日减少3885.0户，减幅为7.49%。业绩披露要点金河生物2026年一季报显示，公司主营收入7.42亿元，同比上升18.67%；归母净利润6229.71万元，同比上升21.87%；扣非净利润6000.15万元，同比上升22.6%；负债率57.03%，投资收益1.14万元，财务费用2591.55万元，毛利率35.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631252024","title":"金河生物（002688）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2631252024","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631252024?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:36","pubTimestamp":1777502168,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金河生物发布2026年一季报。截至本报告期末，公司营业总收入7.42亿元，同比上升18.67%，归母净利润6229.71万元，同比上升21.87%。本报告期金河生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达2141.8%。去年的净利率为-0.38%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631214535","title":"股市必读：金河生物年报 - 第四季度单季净利润同比下降722.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631214535","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631214535?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:47","pubTimestamp":1777495622,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2026年3月31日，金河生物股东户数为4.8万户，较2025年12月31日减少3885.0户，减幅7.49%；户均持股数量由1.49万股增至1.6万股，户均持股市值为9.32万元。业绩披露要点财务报告金河生物2025年实现主营收入28.78亿元，同比增长21.41%；归母净利润2755.67万元，同比下降72.5%；扣非净利润1564.83万元，同比下降81.32%。2025年第四季度单季主营收入8.42亿元，同比增长18.02%；单季度归母净利润-1.12亿元，同比下降722.31%；单季度扣非净利润-1.09亿元，同比下降482.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000014915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582562","title":"图解金河生物年报：第四季度单季净利润同比下降722.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582562","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631582562?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:18","pubTimestamp":1777396702,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物2025年年报显示，当年度公司主营收入28.78亿元，同比上升21.41%；归母净利润2755.67万元，同比下降72.5%；扣非净利润1564.83万元，同比下降81.32%；其中2025年第四季度，公司单季度主营收入8.42亿元，同比上升18.02%；单季度归母净利润-1.12亿元，同比下降722.31%；单季度扣非净利润-1.09亿元，同比下降482.55%；负债率55.73%，投资收益-262.79万元，财务费用9241.08万元，毛利率33.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900003668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629891511","title":"金河生物（002688）股东内蒙古金河控股有限公司质押2870万股，占总股本3.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629891511","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629891511?lang=zh_cn&edition=full","pubTime":"2026-04-24 12:38","pubTimestamp":1777005482,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物4月24日公开信息显示，股东内蒙古金河控股有限公司向红塔证券股份有限公司合计质押2870.0万股，占总股本3.73%。质押详情见下表：截止本公告日，股东内蒙古金河控股有限公司已累计质押股份8655.0万股，占其持股总数的39.49%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400037555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628741215","title":"金河生物（002688）股东内蒙古金河控股有限公司质押1505万股，占总股本1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628741215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628741215?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:22","pubTimestamp":1776680544,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物4月20日公开信息显示，股东内蒙古金河控股有限公司向中国银河证券股份有限公司合计质押1505.0万股，占总股本1.96%。质押详情见下表：截止本公告日，股东内蒙古金河控股有限公司已累计质押股份7635.0万股，占其持股总数的34.83%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000028393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625585914","title":"金河生物：猪口蹄疫合成肽疫苗正在申请创新性评价注册工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2625585914","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625585914?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:03","pubTimestamp":1775638984,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)04月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有没有口蹄疫疫苗？有没有在研发新的口蹄疫疫苗？谢谢金河生物回复：您好，公司猪口蹄疫合成肽疫苗正在申请创新性评价注册工作，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800026063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","159646","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625143179","title":"金河生物：虾青素产品为红法夫酵母代谢产物","url":"https://stock-news.laohu8.com/highlight/detail?id=2625143179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625143179?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:00","pubTimestamp":1775638834,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物04月08日在投资者关系平台上答复投资者关心的问题。是否可应用于医美抗衰领域？产品进展如何 产业化了没有？谢谢金河生物回复：您好，虾青素依托其极强的抗氧化能力，可应用于保健食品、水产养殖、饲料、制药、化妆品等领域。公司的虾青素产品是红法夫酵母在发酵过程中的代谢产物，与红海藻提取的天然虾青素均为左旋结构，同时较天然提取法产量高、成本低。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800026003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625087536","title":"股市必读：金河生物（002688）4月3日收盘跌5.7%，主力净流出3471.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625087536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625087536?lang=zh_cn&edition=full","pubTime":"2026-04-07 01:01","pubTimestamp":1775494873,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，金河生物报收于5.79元，下跌5.7%，换手率4.59%，成交量34.31万手，成交额2.02亿元。来自资金流向：4月3日主力资金净流出3471.09万元，占总成交额17.15%。交易信息汇总4月3日金河生物收盘报5.79元，跌5.7%，当日成交3431.02万元。前10个交易日资金流向情况：主力资金累计净流入320.88万元，股价累计下跌1.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315641","title":"金河生物（002688）披露2023年限制性股票激励计划部分已授予限制性股票回购注销完成公告，3月30日股价上涨0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315641","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623315641?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:51","pubTimestamp":1774864299,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘，金河生物报收于5.94元，较前一交易日上涨0.68%，最新总市值为45.71亿元。该股当日开盘5.86元，最高6.01元，最低5.84元，成交额达4392.89万元，换手率为0.99%。公告显示，本次回购注销涉及2023年限制性股票激励计划中48名激励对象已获授但尚未解除限售的限制性股票，合计2,130,000股，占回购前总股本的0.28%。本次回购注销完成后，公司总股本由771,634,398股变更为769,504,398股。相关股份已于2026年3月26日在中国证券登记结算有限责任公司深圳分公司完成注销手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621743953","title":"股市必读：金河生物（002688）3月20日收盘跌5.83%，主力净流出4340.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621743953","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621743953?lang=zh_cn&edition=full","pubTime":"2026-03-23 01:04","pubTimestamp":1774199052,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，金河生物报收于5.81元，下跌5.83%，换手率3.25%，成交量24.28万手，成交额1.45亿元。交易信息汇总股价提醒3月20日金河生物收盘报5.81元，跌5.83%，当日成交2427.51万元。根据收盘数据统计，该股已连续2日下跌。资金流向3月20日主力资金净流出4340.98万元；游资资金净流入1915.15万元；散户资金净流入2425.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300000382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618895119","title":"金河生物（002688）披露关于注销部分募集资金专户的公告，3月10日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618895119","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618895119?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:47","pubTimestamp":1773154034,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，金河生物报收于6.12元，较前一交易日上涨0.49%，最新总市值为47.22亿元。该股当日开盘6.11元，最高6.14元，最低6.09元，成交额达4557.95万元，换手率为1.0%。近日，金河生物科技股份有限公司发布《关于注销部分募集资金专户的公告》。控股子公司金河佑本已注销该项目对应的募集资金专户。同时，公司已归还临时补充流动资金的闲置募集资金，并注销相关临时补流专户。上述账户注销后，相应的募集资金四方监管协议终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616598355","title":"金河生物（002688）披露变更募集资金用途后重新开立募集资金专户并签订监管协议公告，3月4日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616598355","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616598355?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:30","pubTimestamp":1772634631,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，金河生物报收于5.94元，较前一交易日下跌0.67%，最新总市值为45.84亿元。该股当日开盘5.93元，最高6.0元，最低5.9元，成交额达6175.94万元，换手率为1.39%。近日，金河生物发布《关于变更募集资金用途后重新开立募集资金专户并签订募集资金监管协议的公告》。本次涉及的募集资金为2020年非公开发行股票所得，实际募集资金净额802,243,601.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616340573","title":"金河生物：美伊冲突对公司海外市场影响甚微","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616340573?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:51","pubTimestamp":1772542281,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问美伊冲突升级对贵公司的业务会否产生影响？谢谢金河生物回复：您好，美伊冲突对公司海外市场影响甚微，公司化药产品主要海外市场是美国、加拿大、南美、欧洲、东南亚等国家和地区。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300041986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614852776","title":"金河生物（002688）披露2026年第二次临时股东会决议，2月27日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614852776","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614852776?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:54","pubTimestamp":1772204053,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，金河生物报收于6.29元，较前一交易日上涨0.16%，最新总市值为48.54亿元。金河生物于近日发布《2026年第二次临时股东会决议的公告》。公告显示，公司于2026年2月27日召开2026年第二次临时股东会，会议由董事会召集，董事长王东晓主持，采用现场与网络投票结合方式召开。出席会议股东及授权代表共440名，代表有表决权股份总数247,285,941股，占公司有表决权股份总数的32.6315%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608858090","title":"金河生物：2025年公司全面开辟国内反刍动物及海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2608858090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608858090?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:05","pubTimestamp":1770015922,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物02月02日在投资者关系平台上答复投资者关心的问题。2024年公司计提了2800万元的库存商品跌价准备。2025年公司全面开辟国内反刍动物及海外市场，销量增加，库存下降，且呈现持续良好态势，感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200015144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779364358499,"stockEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":-0.0034},{"period":"3month","weight":-0.0506},{"period":"6month","weight":-0.0235},{"period":"1year","weight":-0.1699},{"period":"ytd","weight":-0.0218}],"compareEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.2312},{"period":"ytd","weight":0.0487}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金河生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47987人(较上一季度减少7.49%)","perCapita":"15576股","listingDate":"2012-07-13","address":"内蒙古自治区呼和浩特市托克托县新坪路71号","registeredCapital":"76950万元","survey":" 金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化学药品、兽用生物制品、药物饲料添加剂、环保业务、淀粉及联产品。","listedPrice":18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金河生物,002688,金河生物股票,金河生物股票老虎,金河生物股票老虎国际,金河生物行情,金河生物股票行情,金河生物股价,金河生物股市,金河生物股票价格,金河生物股票交易,金河生物股票购买,金河生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}